Literature DB >> 20150522

Effect of a high-fat meal on the pharmacokinetics of saxagliptin in healthy subjects.

Chirag G Patel1, Jenny Zhang, Li Li, Lara Gooding, Robert Croop, Tong Li, David W Boulton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20150522     DOI： 10.1177/0091270009360532

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  8 in total

1.  Pharmacokinetic study of saxagliptin in healthy Chinese subjects.

Authors:  Haiyan Li; Li Yang; Conrad K P Tou; Chirag G Patel; June Zhao
Journal:  Clin Drug Investig       Date:  2012-07-01       Impact factor: 2.859

Review 2.  Comparative clinical pharmacokinetics of dipeptidyl peptidase-4 inhibitors.

Authors:  Larry K Golightly; Caitlin C Drayna; Michael T McDermott
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

Review 3.  Saxagliptin: a review of its use as combination therapy in the management of type 2 diabetes mellitus in the EU.

Authors:  Lily P H Yang
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

Review 4.  Clinical Pharmacokinetics and Pharmacodynamics of Saxagliptin, a Dipeptidyl Peptidase-4 Inhibitor.

Authors:  David W Boulton
Journal:  Clin Pharmacokinet       Date:  2017-01       Impact factor: 6.447

Review 5.  The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a systematic review of current evidence on human studies.

Authors:  Meysam Zarezadeh; Ahmad Saedisomeolia; Mahoor Shekarabi; Masoud Khorshidi; Mohammad Reza Emami; Daniel J Müller
Journal:  Eur J Nutr       Date:  2020-11-03       Impact factor: 5.614

6.  Saxagliptin for type 2 diabetes.

Authors:  Antonio R Chacra
Journal:  Diabetes Metab Syndr Obes       Date:  2010-09-22       Impact factor: 3.168

7.  Application of Physiologically-Based Pharmacokinetic Modeling to Predict Gastric pH-Dependent Drug-Drug Interactions for Weak Base Drugs.

Authors:  Zhongqi Dong; Jia Li; Fang Wu; Ping Zhao; Sue-Chih Lee; Lillian Zhang; Paul Seo; Lei Zhang
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-07-31

8.  Bioequivalence of saxagliptin/dapagliflozin fixed-dose combination tablets compared with coadministration of the individual tablets to healthy subjects.

Authors:  Blisse Vakkalagadda; Marion L Vetter; Jignasa Rana; Charles H Smith; Jian Huang; Jennifer Karkas; David W Boulton; Frank LaCreta
Journal:  Pharmacol Res Perspect       Date:  2016-01-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.